1. Home
  2. WGS vs SWI Comparison

WGS vs SWI Comparison

Compare WGS & SWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • SWI
  • Stock Information
  • Founded
  • WGS 2017
  • SWI 1999
  • Country
  • WGS United States
  • SWI United States
  • Employees
  • WGS N/A
  • SWI N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • SWI Computer Software: Prepackaged Software
  • Sector
  • WGS Technology
  • SWI Technology
  • Exchange
  • WGS Nasdaq
  • SWI Nasdaq
  • Market Cap
  • WGS 2.0B
  • SWI 2.4B
  • IPO Year
  • WGS N/A
  • SWI 2009
  • Fundamental
  • Price
  • WGS $69.48
  • SWI $14.06
  • Analyst Decision
  • WGS Strong Buy
  • SWI Hold
  • Analyst Count
  • WGS 5
  • SWI 7
  • Target Price
  • WGS $80.60
  • SWI $14.71
  • AVG Volume (30 Days)
  • WGS 787.4K
  • SWI 497.4K
  • Earning Date
  • WGS 02-18-2025
  • SWI 02-06-2025
  • Dividend Yield
  • WGS N/A
  • SWI N/A
  • EPS Growth
  • WGS N/A
  • SWI N/A
  • EPS
  • WGS N/A
  • SWI 0.22
  • Revenue
  • WGS $267,228,000.00
  • SWI $784,725,000.00
  • Revenue This Year
  • WGS $43.70
  • SWI $5.08
  • Revenue Next Year
  • WGS $17.28
  • SWI $3.04
  • P/E Ratio
  • WGS N/A
  • SWI $63.14
  • Revenue Growth
  • WGS 29.41
  • SWI 4.96
  • 52 Week Low
  • WGS $2.85
  • SWI $10.14
  • 52 Week High
  • WGS $98.87
  • SWI $14.94
  • Technical
  • Relative Strength Index (RSI)
  • WGS 40.28
  • SWI 50.59
  • Support Level
  • WGS $66.81
  • SWI $13.53
  • Resistance Level
  • WGS $98.87
  • SWI $14.20
  • Average True Range (ATR)
  • WGS 7.98
  • SWI 0.27
  • MACD
  • WGS -2.10
  • SWI -0.05
  • Stochastic Oscillator
  • WGS 8.33
  • SWI 56.38

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About SWI SolarWinds Corporation

SolarWinds Corp is a provider of information technology (IT), and management software. Company offers full-stack observability solutions. The company's business is focused on building products that enable technology professionals and leaders to securely monitor and manage the performance of their IT environments, whether on-premises, in the cloud or in hybrid deployments. The products offered are designed to monitor and manage networks, systems, databases and applications across on-premises, multi-cloud and hybrid IT environments without the need for customization or professional services.

Share on Social Networks: